Kassirer Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Kassirer Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,000	Closed	-$455K	–	51
2018 Q4	$455K	Hold	6,000	–	–	0.42%	36
2018 Q3	$480K	Hold	6,000	–	–	0.31%	48
2018 Q2	$596K	Buy	+6,000	New	+$518K	0.38%	47

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

GAM

Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Kassirer Asset Management's CBPO Position: Q1 2019 in Review

Kassirer Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2019, closing a stake of 6,000 shares — an estimated $455K sold.

Kassirer Asset Management first reported a position in CBPO in Q2 2018 and held it in 3 quarters. The position peaked at $596K in Q2 2018. 69 funds tracked by Wall St. Rank hold CBPO as of Q1 2019.

Kassirer Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
Kassirer Asset Management sold 6,000 China Biologic Products Holdings, Inc. shares in Q1 2019, an estimated $455K.
Kassirer Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2018 and held it in 3 quarters.
Kassirer Asset Management's China Biologic Products Holdings, Inc. position peaked at $596K in Q2 2018.
69 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2019.

Based on Kassirer Asset Management's 13F filing for Q1 2019, filed 10 May 2019.